340 related articles for article (PubMed ID: 32476261)
1. Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.
Morillas JA; Marco Canosa F; Srinivas P; Asadi T; Calabrese C; Rajendram P; Budev M; Poggio ED; Narayanan Menon KV; Gastman B; Koval C
Am J Transplant; 2020 Nov; 20(11):3191-3197. PubMed ID: 32476261
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study.
Pereira MR; Aversa MM; Farr MA; Miko BA; Aaron JG; Mohan S; Cohen DJ; Husain SA; Ratner LE; Arcasoy S; Uriel N; Zheng EX; Fox AN; Tsapepas DS; Emond JC; Verna EC
Am J Transplant; 2020 Nov; 20(11):3198-3205. PubMed ID: 32946668
[TBL] [Abstract][Full Text] [Related]
3. Use of tocilizumab in kidney transplant recipients with COVID-19.
Pérez-Sáez MJ; Blasco M; Redondo-Pachón D; Ventura-Aguiar P; Bada-Bosch T; Pérez-Flores I; Melilli E; Sánchez-Cámara LA; López-Oliva MO; Canal C; Shabaka A; Garra-Moncau N; Martín-Moreno PL; López V; Hernández-Gallego R; Siverio O; Galeano C; Espí-Reig J; Cabezas CJ; Rodrigo MT; Llinàs-Mallol L; Fernández-Reyes MJ; Cruzado-Vega L; Pérez-Tamajón L; Santana-Estupiñán R; Ruiz-Fuentes MC; Tabernero G; Zárraga S; Ruiz JC; Gutiérrez-Dalmau A; Mazuecos A; Sánchez-Álvarez E; Crespo M; Pascual J;
Am J Transplant; 2020 Nov; 20(11):3182-3190. PubMed ID: 32654422
[TBL] [Abstract][Full Text] [Related]
4. A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients.
Ringer M; Azmy V; Kaman K; Tang D; Cheung H; Azar MM; Price C; Malinis M
Transpl Infect Dis; 2021 Apr; 23(2):e13556. PubMed ID: 33378571
[TBL] [Abstract][Full Text] [Related]
5. Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience.
Bossini N; Alberici F; Delbarba E; Valerio F; Manenti C; Possenti S; Econimo L; Maffei C; Pola A; Terlizzi V; Salviani C; Moscato M; Pasquali S; Zambetti N; Tonoli M; Affatato S; Pecchini P; Viola FB; Malberti F; Depetri G; Gaggiotti M; Scolari F;
Am J Transplant; 2020 Nov; 20(11):3019-3029. PubMed ID: 32627319
[TBL] [Abstract][Full Text] [Related]
6. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Tschopp J; L'Huillier AG; Mombelli M; Mueller NJ; Khanna N; Garzoni C; Meloni D; Papadimitriou-Olivgeris M; Neofytos D; Hirsch HH; Schuurmans MM; Müller T; Berney T; Steiger J; Pascual M; Manuel O; van Delden C;
Am J Transplant; 2020 Oct; 20(10):2876-2882. PubMed ID: 32412159
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States.
Fung M; Chiu CY; DeVoe C; Doernberg SB; Schwartz BS; Langelier C; Henrich TJ; Yokoe D; Davis J; Hays SR; Chandran S; Kukreja J; Ng D; Prostko J; Taylor R; Reyes K; Bainbridge E; Bond A; Chin-Hong P; Babik JM
Am J Transplant; 2020 Nov; 20(11):3225-3233. PubMed ID: 32476258
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
Pereira MR; Mohan S; Cohen DJ; Husain SA; Dube GK; Ratner LE; Arcasoy S; Aversa MM; Benvenuto LJ; Dadhania DM; Kapur S; Dove LM; Brown RS; Rosenblatt RE; Samstein B; Uriel N; Farr MA; Satlin M; Small CB; Walsh TJ; Kodiyanplakkal RP; Miko BA; Aaron JG; Tsapepas DS; Emond JC; Verna EC
Am J Transplant; 2020 Jul; 20(7):1800-1808. PubMed ID: 32330343
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients.
Gaston DC; Malinis M; Osborn R; Peaper DR; Landry M; Juthani-Mehta M; Azar MM
Am J Transplant; 2021 Mar; 21(3):1304-1311. PubMed ID: 33043603
[TBL] [Abstract][Full Text] [Related]
13. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain.
Loinaz C; Marcacuzco A; Fernández-Ruiz M; Caso O; Cambra F; San Juan R; Justo I; Calvo J; García-Sesma A; Manrique A; Pérez-Jacoiste Asín MA; Folgueira MD; Aguado JM; Lumbreras C
Transpl Infect Dis; 2020 Oct; 22(5):e13372. PubMed ID: 32562561
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in lung transplant recipients: A single center case series from New York City.
Aversa M; Benvenuto L; Anderson M; Shah L; Robbins H; Pereira M; Scheffert J; Carroll M; Hum J; Nolan M; Reilly G; Lemaitre P; Stanifer BP; D'Ovidio F; Sonett J; Arcasoy S;
Am J Transplant; 2020 Nov; 20(11):3072-3080. PubMed ID: 32881315
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 in solid organ transplant recipients.
Danziger-Isakov L; Blumberg EA; Manuel O; Sester M
Am J Transplant; 2021 Mar; 21(3):925-937. PubMed ID: 33319449
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region.
Maritati F; Cerutti E; Zuccatosta L; Fiorentini A; Finale C; Ficosecco M; Cristiano F; Capestro A; Balestra E; Taruscia D; Vivarelli M; Donati A; Perna GP; Giacometti A; Tavio M; Onesta M; Di Sante L; Ranghino A
Transpl Infect Dis; 2020 Oct; 22(5):e13377. PubMed ID: 32573895
[TBL] [Abstract][Full Text] [Related]
18. Effects of Coronavirus Disease 2019 on Solid Organ Transplantation.
Aziz H; Lashkari N; Yoon YC; Kim J; Sher LS; Genyk Y; Kwon YK
Transplant Proc; 2020 Nov; 52(9):2642-2653. PubMed ID: 33127076
[TBL] [Abstract][Full Text] [Related]
19. ARDS in solid organ transplant recipients hospitalized for COVID-19 based on the 2023 new definition.
Tang J; Zhou Y; Gong L; Deng J; Yuan Y; Zhong Y; Li J; Wang G
Heart Lung; 2024; 66():103-107. PubMed ID: 38604053
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence.
Pelaia C; Calabrese C; Garofalo E; Bruni A; Vatrella A; Pelaia G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
